AzTrials
AzTrials

Stress-related ProblemEASY-PEP-iNCT06650696

Effects of Parent-Adolescent Joint I-Interventions for Adolescents with Adverse Childhood Experiences

A study testing PCE promotion, Psychoeducation and Emotiaonl skill enhancement in people with Stress-related Problem and Stress, Emotional, run by Peking University at 1 site in China.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The study aims to examine the effectiveness of internet-based Parent-Adolescent Joint Interventions in improving the mental health outcomes of participants, specifically by reducing symptoms of depression, anxiety, and PTSD, as measured by the Patient Health Questionnaire (PHQ-9), the Generalized Anxiety Disorder-7… Read more about this study

Who is it for?
Ages 10 to 18 yearsHealthy volunteers can take part
Conditions the study is for
Stress-related Problem, Stress, Emotional
What is being tested?
PCE promotion, Psychoeducation and Emotiaonl skill enhancement
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
1 siteChina
Study dates
27 Sep 2024to 31 Dec 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 10 to 18 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Middle school students studying in school and their parents
  • Capable of hearing, speaking, reading, and writing

Who cannot join

  • High suicidal risks
  • Severe mental disorders

Trial locations and contacts

1 site in 1 country.

China1 site
  • Diannan middle school

    Baoding, Hebei

Other trials in China

About this study

Official title: Effects of Parent-Adolescent Joint Internet Interventions for Adolescents with Adverse Childhood Experiences: a Cluster Randomized Controlled Trial

The study aims to examine the effectiveness of internet-based Parent-Adolescent Joint Interventions in improving the mental health outcomes of participants, specifically by reducing symptoms of depression, anxiety, and PTSD, as measured by the Patient Health Questionnaire (PHQ-9), the Generalized Anxiety Disorder-7 scale (GAD-7), and the Child PTSD Symptom Scale for DSM-5 (CPSS-5). Adolescents will be recruited from middle schools and randomly assigned to one of three groups: (a) psychoeducation, (b) psychoeducation + emotional skills enhancement, or (c) psychoeducation + emotional skills enhancement + positive childhood experience promotion. The school-based intervention will consist of 4-8 sessions, with assessments conducted at baseline, post-treatment, and a 3-month follow-up. Investigators will conduct multilevel models (MLMs) and structural equation models (SEMs) to investigate the impact of Adverse Childhood Experiences (ACEs), Positive Childhood Experiences (PCEs), alexithymia, and emotion regulation abilities on mental health outcomes in adolescents.

Being tested
PCE promotion, Psychoeducation, Emotiaonl skill enhancement
Keywords
adolescents, randomized controlled trial, PTSD, ACE, depression, anxiety
Medical subject headings
Stress, Psychological, Stress Disorders, Post-Traumatic, Depression, Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PCE promotionBehavioural

    The intervention requires parents to complete a weekly parent-child interaction task online designed to foster positive childhood experiences. Parents will engage in structured activities with their children and document the interactions. Each week, they are expected to upload a report.

  • PsychoeducationBehavioural

    Psychoeducation includes sessions for both parents and adolescents, covering key topics such as stress, emotional distress, and mental disorders. The content provides foundational knowledge to help participants understand and manage these challenges.

  • Emotiaonl skill enhancementBehavioural

    This intervention combines online material with practical, emotion-focused activities. Participants will receive training online on emotional awareness and emotion regulation strategies, along with completing weekly writing assignments. These assignments focus on recent negative events and the emotions associated with them, encouraging emotional expression and processing.

Study groups in NCT06650696
Study groupRoleWhat they receive
Psychoeducation group (PsyE)Active comparatorPsychoeducation consists of parent and adolescent psychoeducation. The content includes an introduction to stress, emotional distress and mental disorders.
Receives: Behavioral: Psychoeducation
Psychoeducation + Emotional Skills (PsyE+EmoS)ExperimentalPsychoeducation includes sessions for both parents and adolescents, offering the same content as the control group, which introduces stress, emotional distress, and mental disorders via online programe. In addition, the emotional skills enhancement sessions provide online materials focused on emotional awareness and emotion regulation strategies, along with tasks related to the content. Participants will also be required to complete a weekly writing assignment, upload their written contents, and assess their level of subjective discomfort following each writing exercise.
Receives: Behavioral: Psychoeducation; Behavioral: Emotiaonl skill enhancement
Psychoeducation + emotional skills + PCE (PsyE+EmoS+PoCE)ExperimentalIn comparison to the PsyE+EmoS group, this group additionally requires parents to complete a weekly parent-child communication task via online programe aimed at fostering positive childhood experiences. Parents are also expected to document and upload the details of these tasks each week.
Receives: Behavioral: PCE promotion; Behavioral: Psychoeducation; Behavioral: Emotiaonl skill enhancement

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Alexithymia

    A 36-item Peking alexithymia scale measures thoughts and behaviors that prevent people from feeling or recognizing negative emotions on a 5-point Likert scale (1 to 5, and total scores vary from 36 to 180). A higher score represents more severe alexithymia.

    Measured: baseline, post treatment(1 month), 3 month follow-up

  2. Irritability

    A 17-item irritability measurement scale, the Peking irritability scale, measures impulsive emotions, thoughts, and behaviors on a 5-point Likert scale (score from 1 to 5, and total score varies from 17 to 85). A higher score represents higher irritability.

    Measured: baseline, post treatment(1 month), 3 month after post treatment

  3. PTSD for adolescents

    The Child PTSD Symptom Scale for DSM-5 (CPSS-5) for adolescents and children (scores from 0 to 4, and total scores vary from 0 to 80). A higher score represents worse PTSD symptoms.

    Measured: baseline, post treatment(1 month), 3 month after post treatment

  4. Resilience

    A 10-item resilience measurement scale, the Connor-Davidson resilience scale, measures resilience on a 5-point Likert scale (score from 0 to 4, and total score varies from 0 to 40). A higher score represents better resilience .

    Measured: baseline, post treatment(1 month), 3 month after post treatment

  5. Emotion awareness

    A 30-item Emotion awareness questionnaire measures emotion awareness on a 3-point Likert scale (1 to 3, and total scores vary from 30 to 90). A higher score represents better emotion awareness.

    Measured: baseline, post treatment(1 month), 3 month after post treatment

  6. Emotion regulation

    An 18-item cognitive emotion regulation questionnaire measures the ability of emotion regulation on a 5-point Likert scale (1 to 5, and total scores vary from 18 to 90). A higher score represents better emotion regulation.

    Measured: baseline, post treatment(1 month), 3 month after post treatment

  7. Depression

    The 9-item patient health questionnaire (PHQ-9) for adults (score from 0 to 3, and total score varies from 0 to 27). A higher score represents worse depression symptoms.

    Measured: baseline, post treatment(1 month), 3 month after post treatment

  8. Generalized anxiety disorder

    The Generalized Anxiety Disorder-7 scale (GAD-7) for adults, adolescents, and children (scored from 0 to 3, and total score from 0 to 21). A higher score represents worse anxiety symptoms.

    Measured: baseline, post treatment(1 month), 3 month after post treatment

Secondary outcomes (4)
  1. Self-esteem

    A 10-item self-esteemmeasurement scale, Rosenberg self-esteem scale, measures self-esteem on a 4-point Likert scale (score from 0 to 3, and total score varies from 0 to 30), with higher scores indicating greater self-esteem.

    Measured: baseline, post treatment(1 month), 3 month after post treatment

  2. Subjective Happiness Scale

    A 4-item subjective happiness scale measures happiness (score from 1 to 7, and total score vary from 4 to 28). A higher score represents a happier state.

    Measured: baseline, post treatment(1 month), 3 month after post treatment

  3. Seeking for help

    A 10-item help-seeking scale measures on a 7-point Likert scale (score from 1 to 7, and total score varies from 10 to 70), with higher scores indicating greater willingness to seek help from others.

    Measured: baseline, post treatment(1 month), 3 month after post treatment

  4. Insomnia Severity

    The severity of insomnia symptoms will be assessed using the Insomnia Severity Index (ISI). This 7-item self-report measurement evaluates the severity of insomnia symptoms, the level of satisfaction with sleep, interference with daily functioning, noticeability of impairment attributed to sleep problems, and the level of distress caused by sleep disturbance (score from 0 to 4, and total score vary from 0 to 32). Each item is rated on a 5-point scale, providing a comprehensive measure of insomnia severity.

    Measured: baseline, post treatment(1 month), 3 month after post treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Oct 2024
  2. Study start27 Sep 2024
  3. Primary completion30 Jun 2025 (estimated)
  4. Study completion31 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06650696
Sponsor's protocol ID
Joint i-Tx for Adolscents ACEs
Acronym
EASY-PEP-i
Status last verified
Nov 2024
First submitted
18 Oct 2024
Last updated
2 Dec 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing PCE promotion, Psychoeducation and Emotiaonl skill enhancement in people with Stress-related Problem and Stress, Emotional, run by Peking University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 2 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Alexithymia (time frame: baseline, post treatment(1 month), 3 month follow-up). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Dec 2024; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in